Africa CDC partners with PANTHER to advance Mpox treatment research
GERMANY—The Africa Centres for Disease Control and Prevention (Africa CDC), in partnership with...
Read MoreSelect Page
Nov 8, 2024
GERMANY—The Africa Centres for Disease Control and Prevention (Africa CDC), in partnership with...
Read MoreNov 5, 2024
DENMARK—Bavarian Nordic has taken steps to widen the reach of its MVA-BN mpox/smallpox vaccine by...
Read MoreOct 24, 2024
DENMARK—Novo Nordisk has announced promising results from the SOUL cardiovascular outcomes...
Read MoreOct 15, 2024
USA—The US pharmaceutical giant Pfizer has announced that the US Food and Drug Administration...
Read MoreOct 9, 2024
UK—Kyowa Kirin International (KKI), a global speciality pharmaceutical company, has announced that...
Read MoreOct 1, 2024
USA — Johnson & Johnson has filed a supplemental Biologics License Application (sBLA) with the...
Read MoreSep 22, 2024
GERMANY—Boehringer Ingelheim, a global biopharmaceutical company known for its human and animal...
Read MoreSep 12, 2024
UK—GSK, a British pharmaceutical company, published positive results from a mid-stage trial of its...
Read MoreSep 11, 2024
UK—British drugmaker GSK has announced that its asthma drug, Nucala (mepolizumab), has achieved...
Read MoreAug 22, 2024
USA—Johnson & Johnson has received FDA approval for RYBREVANT® (amivantamab-vmjw) combined...
Read More